Skip to main content
ENSC
NASDAQ Life Sciences

Ensysce Q3 Loss of $4.52/Share Blows Past 12-Cent Consensus as Revenue Jumps 342%

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.38
Mkt Cap
$7.534M
52W Low
$0.23
52W High
$2.17
52W Position info
65% above low
Off High info
82% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ENSC sits 65% above its 52-week low of $0.23.

Summary

Ensysce posted a Q3 adjusted loss of $4.52 per share, far wider than the 12-cent loss two analysts expected and outside the -19 cent to -5 cent range. Revenue rose 342.5% to $2.18 million, beating the $1.28 million consensus, but the quarter still produced an $82.11 million net loss. The gap between the headline EPS miss and the revenue beat is the key tension here — the loss is driven by non-operating items tied to the Series C financing and Cy Biopharma deal rather than the core business, which is why revenue matters more than the EPS line. This lands hours after the 10-Q, which showed $29.7 million in cash but carried a going-concern warning with runway only into the second half of 2027. The stock is down 6.9% this quarter and 57.9% year to date, and the December 14 annual meeting vote on converting Series C preferred into roughly 358.3 million shares is the next hard event — that conversion is the dilution overhang traders are pricing.

At the time of this announcement, ENSC was trading at $0.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5M. The 52-week trading range was $0.23 to $2.17. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ENSC - Latest Insights

ENSC
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.380 info
Change: -$0.0071 (-2%) info
Market Cap: $7.534M info
ENSC
Nov 12, 2026, 4:17 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.380 info
Change: -$0.0071 (-2%) info
Market Cap: $7.534M info
ENSC
Nov 12, 2026, 4:15 PM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3871
Real-time Price: $0.380 info
Change: -$0.0071 (-2%) info
Market Cap: $7.534M info
ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.380 info
Change: +$0.0081 (+2%) info
Market Cap: $7.534M info
ENSC
Oct 30, 2026, 5:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4313
Real-time Price: $0.380 info
Change: -$0.0513 (-12%) info
Market Cap: $7.534M info